Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Susan van den Hof

Biographic Data

ID7758853
NAMESusan van den Hof
GIVEN NAMESSusan van den
FAMILY NAMEHof
SIGNATUREVAN DEN HOF S
AFFILIATIONSTuBerculosis Vaccine Initiative
ORCID0000-0002-2968-9652
VERIFIEDYes
TOTAL WORKS8
TOTAL CITATIONS0
WORKS AS AUTHOR8
WORKS AS EDITOR0
FIRST PUBLICATION YEAR2002
LATEST PUBLICATION YEAR2022
H-INDEX0
  • Budgetary impact of using BPaL for treating extensively drug-resistant tuberculosis

    Open Access•Christiaan Mulder, Stephan Rupert et al.•ARTICLE•BMJ Global Health•2022

    INTRODUCTION: Bedaquiline, pretomanid and linezolid (BPaL) is a new all oral, 6-month regimen comprised of bedaquiline, the new drug pretomanid and linezolid, endorsed by the WHO for use under operational research conditions in patients with extensively drug-resistant tuberculosis (XDR-TB). We quantified per-patient treatment costs and the 5-year budgetary impact of introducing BPaL in Indonesia, Kyrgyzstan and Nigeria. METHODS: Per-patient treat…

  • Acceptability, feasibility, and likelihood of stakeholders implementing the novel BPaL regimen to treat extensively drug-resistant tuberculosis patients

    Open Access•Sarah van de Berg, S E J van de Berg et al.•ARTICLE•BMC Public Health•2021

    Acceptability and feasibility of the BPaL regimen is high among TB stakeholders in Indonesia, Kyrgyzstan, and Nigeria. The majority is willing to start using BPaL as the standard of care for eligible patients despite country-specific health system constraints

  • Strategies to reach and motivate migrant communities at high risk for TB to participate in a latent tuberculosis infection screening program

    Open Access•Ineke Spruijt, Dawit Tesfay Haile et al.•ARTICLE•BMC Public Health•2020

    Eritrean migrant communities can be successfully reached and motivated for LTBI screening and treatment programs, when sufficient (human) resources are in place and community members, well-connected to and trusted by the community, are engaged in the design and execution of the program

  • Knowledge, attitudes, beliefs, and stigma related to latent tuberculosis infection

    Open Access•Ineke Spruijt, Dawit Tesfay Haile et al.•ARTICLE•BMC Public Health•2020

    The inability to differentiate LTBI from TB disease and consequent fear of getting infected by persons with LTBI led to enacted and anticipated stigma comparable to stigma related to TB disease among Eritreans. Additional to continuous culturally sensitive education activities, TB prevention programs should implement evidence-based interventions reducing stigma at all phases in the LTBI screening and treatment cascade

  • Improving detection and notification of tuberculosis cases in students in Shaanxi province, China

    Open Access•Tianhua Zhang, Liujia Guo et al.•ARTICLE•BMC Public Health•2011

    It is feasible and effective to set up cooperation between CDCs and university hospitals to increase the number of TB suspects examined by CDCs and increase the number of TB patients treated under DOTS conditions. These public-public mix (PPM) activities should be expanded to cover all other university hospitals in China

  • Factors associated with low cure rate of tuberculosis in remote poor areas of Shaanxi Province, China

    Open Access•Xianqin Ai, Ke Men et al.•ARTICLE•BMC Public Health•2010

    Interruption of treatment was most strongly associated with non-cure. Although treatment observation by medical staff is preferred, in order to diminish the proportion of patients who do not have a treatment observer and thereby reduce the proportion of patients who interrupt treatment, we suggest making it possible for family members, after sufficient training, to be treatment observers in remote areas where it is logistically difficult to have …

  • A tuberculin skin test survey among Ghanaian school children

    Open Access•Kennedy Kwasi Addo, Susan van den Hof et al.•ARTICLE•BMC Public Health•2010

    Tuberculosis infection is still a public health problem in Ghana and to monitor the trend, the survey needs to be repeated at 5 years interval

  • The average cost of measles cases and adverse events following vaccination in industrialised countries

    Open Access•Hélène Carabin, W John Edmunds et al.•ARTICLE•BMC Public Health•2002

    These average cost estimates could be combined with incidence estimates and costs of immunisation programmes to provide estimates of the cost of measles to industrialised countries. Such estimates could be used as a basis to estimate the potential economic gains of global measles eradication

No prominent works on this page.

  • The average cost of measles cases and adverse events following vaccination in industrialised countries

    Open Access•Hélène Carabin, W John Edmunds et al.•ARTICLE•BMC Public Health•2002

    These average cost estimates could be combined with incidence estimates and costs of immunisation programmes to provide estimates of the cost of measles to industrialised countries. Such estimates could be used as a basis to estimate the potential economic gains of global measles eradication

  • Factors associated with low cure rate of tuberculosis in remote poor areas of Shaanxi Province, China

    Open Access•Xianqin Ai, Ke Men et al.•ARTICLE•BMC Public Health•2010

    Interruption of treatment was most strongly associated with non-cure. Although treatment observation by medical staff is preferred, in order to diminish the proportion of patients who do not have a treatment observer and thereby reduce the proportion of patients who interrupt treatment, we suggest making it possible for family members, after sufficient training, to be treatment observers in remote areas where it is logistically difficult to have …

  • A tuberculin skin test survey among Ghanaian school children

    Open Access•Kennedy Kwasi Addo, Susan van den Hof et al.•ARTICLE•BMC Public Health•2010

    Tuberculosis infection is still a public health problem in Ghana and to monitor the trend, the survey needs to be repeated at 5 years interval

  • Improving detection and notification of tuberculosis cases in students in Shaanxi province, China

    Open Access•Tianhua Zhang, Liujia Guo et al.•ARTICLE•BMC Public Health•2011

    It is feasible and effective to set up cooperation between CDCs and university hospitals to increase the number of TB suspects examined by CDCs and increase the number of TB patients treated under DOTS conditions. These public-public mix (PPM) activities should be expanded to cover all other university hospitals in China

  • Strategies to reach and motivate migrant communities at high risk for TB to participate in a latent tuberculosis infection screening program

    Open Access•Ineke Spruijt, Dawit Tesfay Haile et al.•ARTICLE•BMC Public Health•2020

    Eritrean migrant communities can be successfully reached and motivated for LTBI screening and treatment programs, when sufficient (human) resources are in place and community members, well-connected to and trusted by the community, are engaged in the design and execution of the program

  • Knowledge, attitudes, beliefs, and stigma related to latent tuberculosis infection

    Open Access•Ineke Spruijt, Dawit Tesfay Haile et al.•ARTICLE•BMC Public Health•2020

    The inability to differentiate LTBI from TB disease and consequent fear of getting infected by persons with LTBI led to enacted and anticipated stigma comparable to stigma related to TB disease among Eritreans. Additional to continuous culturally sensitive education activities, TB prevention programs should implement evidence-based interventions reducing stigma at all phases in the LTBI screening and treatment cascade

  • Acceptability, feasibility, and likelihood of stakeholders implementing the novel BPaL regimen to treat extensively drug-resistant tuberculosis patients

    Open Access•Sarah van de Berg, S E J van de Berg et al.•ARTICLE•BMC Public Health•2021

    Acceptability and feasibility of the BPaL regimen is high among TB stakeholders in Indonesia, Kyrgyzstan, and Nigeria. The majority is willing to start using BPaL as the standard of care for eligible patients despite country-specific health system constraints

  • Budgetary impact of using BPaL for treating extensively drug-resistant tuberculosis

    Open Access•Christiaan Mulder, Stephan Rupert et al.•ARTICLE•BMJ Global Health•2022

    INTRODUCTION: Bedaquiline, pretomanid and linezolid (BPaL) is a new all oral, 6-month regimen comprised of bedaquiline, the new drug pretomanid and linezolid, endorsed by the WHO for use under operational research conditions in patients with extensively drug-resistant tuberculosis (XDR-TB). We quantified per-patient treatment costs and the 5-year budgetary impact of introducing BPaL in Indonesia, Kyrgyzstan and Nigeria. METHODS: Per-patient treat…

Medicine (8 works) · Tuberculosis (7 works) · Tuberculosis Research and Epidemiology (7 works) · Biostatistics (6 works) · Internal Medicine (5 works) · Pneumonia and Respiratory Infections (5 works) · Public health (5 works) · Environmental health (4 works) · Epidemiology (4 works) · Family medicine (4 works)

Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae